Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1997-02-06
1999-05-04
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 51, 514912, A61K 3170
Patent
active
059004070
ABSTRACT:
A method and preparation for the stimulation of tear secretion in a subject in need of such treatment is disclosed. The method comprises administering to the ocular surfaces of the subject a purinergic receptor agonist such analogs and derivatives, in an amount effective to stimulate tear fluid secretion. Pharmaceutical formulations and methods of making the same are also disclosed. Methods of administering the same would include: topical administration via a liquid, gel, cream, or as part of a contact lens or selective release membrane; or systemic administration via nasal drops or spray, inhalation by nebulizer or other device, oral form (liquid or pill), injectable, intra-operative instillation or suppository form.
REFERENCES:
patent: 4753945 (1988-06-01), Gilbard et al.
patent: 4868154 (1989-09-01), Gilbard et al.
patent: 5292498 (1994-03-01), Boucher, Jr.
Database Embase Elsevier Science Publishers, Amsterdam NL No. 75036639.
Vovsi, B.M. et al., "Importance of hydrodynamic indices for pathogenic treatment of penetrating wounds of the eye," XP002035486 abstract.
D. Dartt, et al., Exp. Eye Res. 67, 27 (1996).
J. Gilbard, et al., Ophthalmol. 96, 677 (1978).
J. Gilbard, et al., Arch. Ophthal. 109, 672-76 (1991).
J. Gilbard, CLAO Journal, 22(2), 141-45 (1996).
J. Gilbard, et al., Arch. Ophthal. 112, 1614-16 (1994).
J. Gilbard, et al., Inv. Ophthal. Vis. Sci., 31, 1381-88 (1990).
J. Gromada, et al., Eur. J. Physiol. 429, 578 (1995).
G. Grynkiewicz, et al., J. Biol. Chem. 260, 3440-3450 (1985).
T. Inatomi, et al., Inv. Ophthal. Vis. Sci. 37, 1684 (1996).
M. Lemp, Cornea 9(1), S48-S50 (1990).
K. Ng and L.E. Orgel, Nucleic Acids Res. 15 (8), 3573-80(1977).
E. Rapaport, et al., Proc. Natl. Acad. Sci. USA 78, 838-42 (1981).
I. Sasaki, et al., Febs Lett. 264, 130-34 (1990).
I. Sasaki, et al., J. Physiol. 447, 103-18 (1992).
P. Vincent, J. Physiol. 449, 313-31 (1992).
Jacobus Karla M.
Pendergast William
Rideout Janet L.
Yerxa Benjamin R.
Bendrick John A.
Fay Zohreh
Halluin Albert P.
Inspire Pharmaceuticals Inc.
LandOfFree
Method of treating dry eye disease with uridine triphosphates an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating dry eye disease with uridine triphosphates an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating dry eye disease with uridine triphosphates an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1869610